Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
|Articles|February 2, 2018
- Pharmaceutical Technology-02-02-2018
- Volume 42
- Issue 2
Aqueous Sugar Film Coating System
Colorcon's Opadry SGR, Rapid Sugar Film Coating System, is an aqueous, high-gloss sugar film coating system for pharmaceutical products.
Colorcon’s Opadry SGR, Rapid Sugar Film Coating System, is an aqueous, high-gloss sugar film coating system for pharmaceutical products. The coating system delivers a streamlined application process by reducing coating time from days to hours and improving manufacturing safety through the elimination of organic solvents, according to the company. The system is color matched to meet marketing and brand needs and is suited for environments where less automated equipment is prevalent.
Articles in this issue
over 8 years ago
Designing a Single-Use Biopharmaceutical Processover 8 years ago
Analyzing Content Uniformityover 8 years ago
Impurity Testingover 8 years ago
Tabletop Peristaltic Liquid-Filling Machineover 8 years ago
Safety Light Curtain Feature on Tumble Blendersover 8 years ago
USB Data Logger for Temperature-Sensitive Productsover 8 years ago
Navigating Data Integrity in the Modern LabRelated to this article
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Richard Jaenisch weighs how FDA's new NAM rule could reshape preclinical testing and what CMC teams should do now, on Manufacturing Intelligence.
In a preview of their panel discussion at AAPS PharmSci 360 2026, Alfred Rumondor, PhD, AbbVie, and Swita Singh, PhD, Bristol Myers Squibb, discuss the implementation of risk-based approaches for CMC.
Ronald Piervincenzi, USP, urges drugmakers and purchasers to act on supply chain resilience to curb drug shortages and shape better policy.
Content on PharmTech.com this week ranged from fundamentals on the use of digital pathology in drug development, discussions on the use of AI in pharma, and regulatory actions impacting the industry.